These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 988964)

  • 121. Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.
    Krapf R; Gertsch M
    Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1784-5. PubMed ID: 3924255
    [No Abstract]   [Full Text] [Related]  

  • 122. Liver drug metabolism and blood pressure response to a lipophilic and hydrophilic beta blocker.
    Säkö S; Sotaniemi EA; Anttila M
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):81-6. PubMed ID: 3770017
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Singh BN; Deedwania P; Nademanee K; Ward A; Sorkin EM
    Drugs; 1987 Sep; 34(3):311-49. PubMed ID: 3315621
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Comparison of once and twice daily administration of sotalol in the treatment of hypertension.
    Parvinen I; Paukkala E
    Eur J Clin Pharmacol; 1979 Jun; 15(5):293-8. PubMed ID: 378671
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Pharmacokinetics of the -adrenergic blocker sotalol in dogs.
    Schnelle K; Garrett ER
    J Pharm Sci; 1973 Mar; 62(3):362-75. PubMed ID: 4144183
    [No Abstract]   [Full Text] [Related]  

  • 127. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.
    Poirier JM; Jaillon P; Lecocq B; Lecocq V; Ferry A; Cheymol G
    Eur J Clin Pharmacol; 1990; 38(6):579-82. PubMed ID: 2373132
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Observations on the efficacy and pharmacokinetics of sotalol after oral administration.
    Brown HC; Carruthers SG; Kelly JG; McDevitt DG; Shanks RG
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):367-72. PubMed ID: 971701
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Human pharmacokinetics of sotalol.
    Anttila M; Arstila M; Pfeffer M; Tikkanen R; Vallinkoski V; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):118-28. PubMed ID: 988964
    [No Abstract]   [Full Text] [Related]  

  • 131. [Clinical pharmacology of adrenergic beta receptor blockade with sotalol (MJ 1999)].
    Schnelle K
    Adv Clin Pharmacol; 1978; 18():1-111. PubMed ID: 212935
    [No Abstract]   [Full Text] [Related]  

  • 132. Hemodynamic effects of intravenous and oral sotalol.
    Mahmarian JJ; Verani MS; Pratt CM
    Am J Cardiol; 1990 Jan; 65(2):28A-34A; discussion 35A-36A. PubMed ID: 2403732
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 134.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 135.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.